MedTrace Logo

Hematological Markers MPV, PLR, and NLR in Primary Versus Secondary Antiphospholipid Syndrome

NCT07142239 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2025-08-26

No results posted yet for this study

Summary

Antiphospholipid syndrome is a thrombo-inflammatory autoimmune disorder with a complex antiphospholipid antibody-mediated pathogenesis, and high heterogeneity in clinical presentation and disease course. Clinical presentation in antiphospholipid syndrome includes venous and arterial thrombosis, pregnancy complications, and a broad range of microvascular and non-thrombotic manifestations

Conditions

  • Antiphospholipid Syndrome

Interventions

DIAGNOSTIC_TEST

• Complete blood count , MPV

CBC report

DIAGNOSTIC_TEST

Calculation of PLR: Platelet count / Lymphocyte count and Calculation of NLR:

CBC report

DIAGNOSTIC_TEST

Antiphospholipid antibody profile

Patient record

Sponsors & Collaborators

  • New Valley University

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-11-27
Primary Completion
2026-12-30
Completion
2027-06-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07142239 on ClinicalTrials.gov